The Library
Neurokinin 3 receptor antagonism decreases gonadotropin and testosterone secretion in healthy men
Tools
Tools
Tools
Skorupskaite, Karolina, George, Jyothis T., Veldhuis, Johannes D, Millar, Robert P and Anderson, Richard A (2017) Neurokinin 3 receptor antagonism decreases gonadotropin and testosterone secretion in healthy men. Clinical Endocrinology, 87 (6). pp. 748-756. doi:10.1111/cen.13445 ISSN 0300-0664.
|
PDF
WRAP-neurokinin-3-receptor-antagonism-decreases-gonadotropin-George-2017.pdf - Accepted Version - Requires a PDF viewer. Download (1631Kb) | Preview |
Official URL: http://dx.doi.org/10.1111/cen.13445
Abstract
Objective
Patients with mutations of NKB and its receptor show hypogonadotrophic hypogonadism, but there is little evidence for the importance of this pathway in reproductive function in normal men, or its functional hierarchy with kisspeptin.
Design
An open label study wherein men (n=6) were administered the NK3R antagonist MLE4901 40mg orally twice a day for 7 days. Kisspeptin-10 (0.3 μg/kg iv bolus) was given before and on day 7 of NK3R antagonist treatment.
Patients
Subjects were healthy men.
Measurements
Reproductive hormones were measured before and during the NK3R antagonist administration, including frequent sampling on two occasions for analysis of pulsatile LH secretion.
Results
LH, FSH and testosterone secretion were decreased during NK3R antagonist administration. LH showed a biphasic response, being reduced after 24 hours of treatment (4.5±0.6 IU/l pre-treatment to 1.7±0.2 IU/l, p<0.05), with partial recovery thereafter; but it was again decreased on day 7 (2.5±0.6 IU/l, p<0.05 vs pre-treatment). FSH secretion was also suppressed, with a similar temporal pattern to that of LH. Testosterone secretion was decreased from 24 hours (18.4±1.6 pre-treatment vs 5.6±1.5 nmol/l, p<0.01) and remained suppressed throughout the treatment period. Analysis of LH pulsatility showed that both basal and pulsatile LH secretion were markedly suppressed but there was no detected change in LH pulse frequency. Kisspeptin-10 stimulated LH secretion, with similar responses before and during NK3R antagonist administration.
Conclusions
These data demonstrate a central role for NKB/NK3R in the physiological regulation of reproductive function in men, and that this is functionally upstream of kisspeptin-mediated GnRH secretion.
| Item Type: | Journal Article | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Subjects: | Q Science > QP Physiology | |||||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
|||||||||
| SWORD Depositor: | Library Publications Router | |||||||||
| Library of Congress Subject Headings (LCSH): | Tachykinins, Luteinizing hormone releasing hormone, Testosterone | |||||||||
| Journal or Publication Title: | Clinical Endocrinology | |||||||||
| Publisher: | Wiley-Blackwell Publishing Ltd | |||||||||
| ISSN: | 0300-0664 | |||||||||
| Official Date: | December 2017 | |||||||||
| Dates: |
|
|||||||||
| Volume: | 87 | |||||||||
| Number: | 6 | |||||||||
| Page Range: | pp. 748-756 | |||||||||
| DOI: | 10.1111/cen.13445 | |||||||||
| Status: | Peer Reviewed | |||||||||
| Publication Status: | Published | |||||||||
| Access rights to Published version: | Restricted or Subscription Access | |||||||||
| Date of first compliant deposit: | 17 August 2017 | |||||||||
| Date of first compliant Open Access: | 12 August 2019 | |||||||||
| Funder: | Wellcome Trust (London, England), Medical Research Council (Great Britain) (MRC) | |||||||||
| Grant number: | Scottish Translational Medicine and Therapeutics Initiative 102419/Z/13/A (Wellcome Trust (London, England)), Grant G0701682 (MRC) | |||||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
